 |
인쇄하기
취소
|
New drug screening technologies transferring to overseas
A screening technology for the discovery of new drugs has been transferred to the overseas.
The Korea Health Industry Development Institute (KHIDI) announced that the screening system technologies for the development of new drugs owned by Tolgene, a bio engineering venture company of Korea, had been transferred to "M" company of America.
The technology improved one step upward for the swi...
The Korea Health Industry Development Institute (KHIDI) announced that the screening system technologies for the development of new drugs owned by Tolgene, a bio engineering venture company of Korea, had been transferred to "M" company of America.
The technology improved one step upward for the swi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.